Skip to main content

Table 3 Relationship between eosinophil-to-monocyte ratio (EMR) and poor outcome among patients with acute ischemic stroke in different models

From: Eosinophil-to-monocyte ratio is a potential biomarker in the prediction of functional outcome among patients with acute ischemic stroke

Variable Non-adjusted model Model 1 Model 2
OR (95% CI) P OR (95% CI) P OR (95% CI) P
EMR 0.19 (0.08, 0.46) 0.0002 0.23 (0.09, 0.56) 0.0011 0.09 (0.03, 0.34) 0.0003
EMR (quartile)
 Q1 1.0   1.0   1.0  
 Q2 0.60 (0.36, 0.98) 0.0398 0.64 (0.38, 1.07) 0.0869 0.56 (0.29, 1.10) 0.0903
 Q3 0.33 (0.19, 0.55) < 0.0001 0.38 (0.22, 0.66) 0.0005 0.27 (0.13, 0.59) 0.0010
 Q4 0.26 (0.15, 0.45) < 0.0001 0.30 (0.17, 0.52) < 0.0001 0.23 (0.10, 0.52) 0.0005
 P for trend < 0.0001   < 0.0001   < 0.0001  
  1. Non-adjusted model: we did not adjust other covariates
  2. Model 1: we adjusted age and sex
  3. Model 2: we adjusted age, sex, history of hyperlipidemia, history of previous stroke, history of atrial fibrillation, ischemic stroke subtypes, triglyceride, NIHSS score at baseline, premorbid mRS score and proton pump inhibitors treatment
  4. EMR eosinophil-to-monocyte ratio, OR odds ratio